Contact us today for Personalized Peptide Therapy & Functional Medicine.
Recalls & Warnings July 23, 2016 Seller of GlucoCor Warned for Drug Claims On June 30, 2016, the FDA issued a warning letter to MC-COR, LLC, following a review of the company's website and Facebook page which found statements made about its GlucoCor capsules to be drug claims
One of the original pioneers in pharmacy compounding, Las Colinas Pharmacy sustains cutting edge knowledge, technology and quality control procedures
Insulin therapy in type 2 diabetes mellitus
Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats
Eligibility and Safety Considerations Just because tirzepatide is available does not mean it is appropriate for everyone